Similarly, no apparent increase in sensitivity to STLC was observed when using a different isogenic pair of cancer cell lines: SW48 KRAS+/+ and KRASG12D/+ (Supplementary Fig. S9d). The gene discussed is KRAS; the disease is cancer.